---
figid: PMC7912842__cells-10-00293-g001
figtitle: Fibroblast growth factor-FGF receptor (FGF-FGFR) and cyclin D-cyclin-dependent
  kinase (CDK)4/6 pathways in breast cancer
organisms:
- NA
pmcid: PMC7912842
filename: cells-10-00293-g001.jpg
figlink: pmc/articles/PMC7912842/figure/cells-10-00293-f001/
number: F1
caption: Fibroblast growth factor-FGF receptor (FGF-FGFR) and cyclin D-cyclin-dependent
  kinase (CDK)4/6 pathways in breast cancer. The molecular components of these signaling
  pathway and their connections are indicated, together with the available inhibitors
  that target FGF, FGFR, or CDK4/6.
papertitle: Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance
  in Breast Cancer.
reftext: Navid Sobhani, et al. Cells. 2021 Feb;10(2):293.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9348444
figid_alias: PMC7912842__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7912842__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7912842__cells-10-00293-g001.html
  '@type': Dataset
  description: Fibroblast growth factor-FGF receptor (FGF-FGFR) and cyclin D-cyclin-dependent
    kinase (CDK)4/6 pathways in breast cancer. The molecular components of these signaling
    pathway and their connections are indicated, together with the available inhibitors
    that target FGF, FGFR, or CDK4/6.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - PTX3
  - PITX3
  - AR
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - FRS2
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - NFKB1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - C6
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MTOR
  - MAPK3
  - MAPK1
  - TSC2
  - CDKN2A
  - CDKN2D
  - F9
  - REG1A
  - IL23A
  - H3P13
  - CDKN2B
  - MRPL28
  - SUB1
  - NXT1
  - H3P9
  - CDKN2C
  - UBE2I
  - MAFK
  - EEF1E1
  - ZNF197
  - ATRAID
  - LAMTOR1
  - TPPP2
  - H3P12
  - H3P10
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - TP53
  - TP63
  - TP73
  - CCND1
  - CDK6
  - CDK4
  - RPTOR
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1C
  - CORO1A
  - H3P47
  - CDK2
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - CCNE1
  - CCNE2
  - AZD4547
  - Infigratinib
  - Erdafitinib
  - Futibatinib
  - Rogaratinib
  - LY2874455
  - CH5183284
---
